Breaking news
The war between the EU and AstraZeneca deepened on Friday as Brussels published a redacted version of the confidential vaccines contract it signed with the drug-maker. The EU hopes publishing the contract will force AstraZeneca to supply it with millions of jabs manufactured at UK factories to make up for shortfalls at a Belgian plant … Read more
The Novavax coronavirus vaccine could submit its results to the UK regulator within two weeks, says the clinical trial chief, with supplies set to be available this summer. Early results show the jab is 89.3 effective against the virus including the Kent strain in a glimmer of hope the UK could add a fourth jab … Read more
The EU’s vaccine shambles descended further into chaos today as it emerged the bloc has not yet signed a deal to buy British-made Novavax jabs which passed phase III trials yesterday with a 90% success rate. Ministers from the EU commission only completed ‘exploratory’ talks to buy Novavax, which is being made in a Tesside … Read more
The UK’s vaccine chief today revealed she cracked open the wine and ‘broke dry January’ last night after learning another jab set be made in Britain was proved to beat Covid-19. Kate Bingham, who stepped down as chairwoman of the UK Vaccine Taskforce on January 1, also revealed that she was one of the people who took … Read more
Top bosses at drugs company Novavax pocket £34m windfall as Covid-19 vaccine enters late-stage trials By City & Finance Reporter for the Daily Mail Published: 23:39 GMT, 12 January 2021 | Updated: 23:39 GMT, 12 January 2021 Novavax has a potential Covid-19 vaccine and it has entered late-stage trials Top bosses at a drugs company … Read more
Novavax launches final US coronavirus vaccine trial before it could ask FDA for emergency approval of its shot Novavax announced Monday that it has begun its phase 3 trial for its coronavirus vaccine The trial will include up to 30,000 participants in the US and Mexico Novavax aims to provide the US with 100 million … Read more
Novavax delays US trials for its coronavirus vaccine AGAIN and says late-stage study will begin ‘in the coming weeks’ as it struggles to scale up production of its jab Novovax delayed the start of its late-stage US trials for the second time after initially declaring a start date in October and then November The company said … Read more
Novavax Inc announced its experimental vaccine produced a promising immune response against the novel coronavirus, according to early data from clinical trials. The Maryland-based company said participants generated high levels of neutralizing antibodies and T-cells, both of which are needed to build up immunity. What’s more, the levels were higher than those seen among patients … Read more